Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-09-29
1981-02-24
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 12, 23230B, 422 61, G01N 3348, A61K 4300, G01T 100, B65D 7100
Patent
active
042527821
ABSTRACT:
An improved test for assessing the unsaturated binding capacity of serum proteins which bind thyroid hormones employs a clay-organic complex for adsorbing a free radioactive hormone fraction. The sorbent, an organically modified montmorillonite, provides better separation of thyroid states and may be employed in smaller amounts than prior sorbents employed in comparable tests.
REFERENCES:
patent: 2531427 (1950-11-01), Hauser
patent: 3666854 (1972-05-01), Eisentraut
patent: 3743482 (1973-07-01), Eisentraut
patent: 3775615 (1973-11-01), Eisentraut
patent: 3776698 (1973-12-01), Eisentraut
patent: 3947564 (1976-03-01), Shannon et al.
patent: 3996162 (1976-12-01), McCall
Meloy Laboratories Inc.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Test for assessing the unsaturated binding capacity of serum pro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Test for assessing the unsaturated binding capacity of serum pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Test for assessing the unsaturated binding capacity of serum pro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1409061